[go: up one dir, main page]

DD266921A3 - SAUER MILK PRODUCT "BIFILIN" - Google Patents

SAUER MILK PRODUCT "BIFILIN" Download PDF

Info

Publication number
DD266921A3
DD266921A3 DD85273191A DD27319185A DD266921A3 DD 266921 A3 DD266921 A3 DD 266921A3 DD 85273191 A DD85273191 A DD 85273191A DD 27319185 A DD27319185 A DD 27319185A DD 266921 A3 DD266921 A3 DD 266921A3
Authority
DD
German Democratic Republic
Prior art keywords
pacthtejibhoro
mjih
milk
mji
bifilin
Prior art date
Application number
DD85273191A
Other languages
German (de)
Inventor
Evgenija A Chorkova
Vera F Semenichina
Lilia N Ivanova
Marina B Sundukova
Kalerija S Ladodo
Natalja N Semenova
Svetlana M Barasneva
Original Assignee
Vnimi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vnimi filed Critical Vnimi
Publication of DD266921A3 publication Critical patent/DD266921A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die Erfindung betrifft die Molkereiindustrie. Das Sauermilchprodukt enthaelt Eiweissstoffe, Milchfett, Lactose, Minderalstoffe, Vitamin A, Bifidusbakterien und Wasser. Erfindungsgemaess enthaelt das Produkt zusaetzlich Maltodextrin, Saccharose, Pflanzenfett und die Vitamine D2, E, C, B1, B2, B3, B6, BC und PP. Als Mineralstoffe wird ein Eisenpraeparat bei folgenden Verhaeltnissen der Bestandteile in Masseteilen (in %) verwendet:Milch- und Pflanzenfett 3,4...3,6Lactose2,0...2,2Maltodextrin1,6...1,8Saccharose3,3...3,5Eiweissstoffe1,6...1,8WasserRest (zu 100)Bifidusbakterien, Zelleinheiten in 1 ml108...109Eisensulfatpraeparat, ppm32,5...33,5Vitamine, ppm64,0...66,0The invention relates to the dairy industry. The sour milk product contains proteins, milk fat, lactose, nutrients, vitamin A, bifidus bacteria and water. According to the invention, the product additionally contains maltodextrin, sucrose, vegetable fat and vitamins D2, E, C, B1, B2, B3, B6, BC and PP. As minerals, a iron compound is used in the following proportions of the constituents in parts by weight (in%): Milk and vegetable fat 3,4 ... 3,6Lactose2,0 ... 2,2Maltodextrin1,6 ... 1,8Sucrose3,3. ..3.5Engredients1,6 ... 1,8WaterRest (to 100) Bifidobacteria, cell units in 1 ml108 ... 109Eisen sulfate-sulphate, ppm32,5 ... 33,5Vitamin, ppm64,0 ... 66,0

Description

OIMCAHHE H30EFETEHHfl K ABTOPCKOMyOIMCAHHE H30EFETEHHFK ABTOPCKOMy

: ,29.02,84 J5. 3706834/28-03 MM4 A23C 9/12:, 29.02.84 J5. 3706834 / 28-03 MM 4 A23C 9/12

E.A.XopBKOBa, B.ö.CeMeHHXHHa, Jl*H.HBaHOBa, M.B.CyiWKOBa, K.C.üaÄOÄO, H.W.CeMeHOBa, C.M.BapaiiiHeBaE.A. XopBKOBa, B.ö.CeMeHHXHHa, Jl * H.HBaHOBa, M.B. CyyWKOBa, K.C., aaOEO, H.W.CeMeHOBa, C.M.BapaiiiHeBa

BcecoK)3HHH Hay^o-nccjieitOBaTejiBCKHKBcecoK) 3HHH Hay ^ o-nccjieitOBaTejiBCKHK

MOJIOTOOä npOMHUUieHHOCTHMOJIOTOOä npOMHUUieHHOCTH

Ha3EaHne ii30ÖpeTeHHH: KWCJIOMOJIOmii'l ΠΡΟ,Ε,ΤΚΓ "Ha3EaHne ii30ÖpeTeHHH: KWCJIOMOJIOmii'l ΠΡΟ, Ε, ΤΚΓ "

Pl3OOpeTeHHe OTKOCHTCH Κ MOJlO^HOa ΠρΟΜΗΙΐυίβΗΗΟΟΤΗ H MOJKeT OHTB HCnOJIB3OBaHO npE npOH3BOÄCTBePlaOOpeTeHHe OTKOCHTCH Κ MOJlO ^ HOa ΠρΟΜΗΙΐυίβΗΗΟΟΤΗ H MOJKeT OHTB HCnOJIB3OBaHO npE npOH3BOÄCTBe

ηογο npoiyKTa jyiß ΛβτοκοΓΟ jie-qeoHoro nnTaH üejiBio H30Öpe TeHHJJ flBJiseTCH noBHmeHne ueHHOCTH n jie^ieoHHx cboSctb npojiyKTa. CynmocTB n300peTeHHH 3aKjn(raaeTcii B tom, ^to προ-ÄonojiHPiTe-iBHO coÄepKHT ÄeKCTpnH-MajiBTOsy, caxapo-3y, pacTHTeJiBHHii amp, BHTawniHH D1, E, C, Bj, Bg, B3, Bg, B0, PP, a β Ka^e CTBe MHHepaJiBHbix BemecTB HcnojtB3y-MT npenapaT atejie3a npn cjie^yiomiix cooTHOineHHHx κομποηθη-TOB B MaCC.aOJlHX %\ ηογο npoiyKTa yyyy ΛβτοκοΓΟ jie-qeoHoro nnTaH üejiBio H30pee TeHHJJ flBJiseTCH noBHmeHne ueHHoCTH n jie ^ ieoHHx cboSctb npojiyKTa. CynmocTB n300peTeHHH 3aKjn (raaeTcii B tom, ^ to προ-aonojiHPiTe-iBHO coAepKHT ÄeKCTpnH-MajiBTOsy, caxapo-3y, pacTHTeJiBHHii amp, BHTawniHH D 1 , E, C, Bj, Bg, B 3 , Bg, B 0 , PP, a β Ka ^e CTBe MHHepaJiBHbix BemecTB HcnojtB3y-MT npenapaT atejie3a npn cjie ^ yiomiix cooTHOineHHHx κομποηθη-TOB B MaCC.aOJlHX % \

MOJIO^HHÜ H pa CTHTeJIBHHHMOJIO ^ HHU H pa CTHTeJIBHHH

JKHpH 3,4-3,6JKHpH 3,4-3,6

jiaKT03a 2,0-2,2jiaKT03a 2.0-2.2

jte KcTpHH-MajiBT 03a 1,6-1,8jte KcTpHH-MajiBT 03a 1,6-1,8

caxapo3a 3,3-3,5caxapo3a 3,3-3,5

1,6-1,81.6-1.8

B TOM ^HCJIeB TOM ^ HCJIe

Q QQ Q

ΟΒφΗΗΟΟβκτβρκβ, eÄ,KJieTOK β I mji IO -IO npenapaT cepHOKHCJioro scejie3a,ΟΒφΗΗΟΟβκτβρκβ, eÄ, KJieTOK β I mji IO-n npenapaT cepHOKHCJioro scejie3a,

MJiH"1 32,5-33,5MJiH " 1 32.5-33.5

BHTaMHHH, MJIH 64,0-66,0,BHTaMHHH, MJIH 64.0-66.0,

Γ· 1 CJ q 7Γ · 1 CJ q 7

py3Hoe ηλη κοκοcoboe itjik no^cojiHe^HOe ii MacJio η cooTHOiueHHe mojiohhoio h paCTHTejiBHoropy3Hoe ηλη κοκοcoboe itjik no ^ cojiHe ^ HOe ii MacJio η cooTHOiueHHe mojiohhoio h paCTHTejiBHoro

3:13: 1

CooTHOineHiie μολο^ϊηογο η pacTHTejiBHoro ehpob - 3:1 CooTHOineHiie μολο ^ ϊηογο η pacTHTejiBHoro ehpob - 3: 1

otiTHMaJiBHEM, TaK KaK no αθηηημ ne^HaTpoB ημθη-HO 25% pacTwreJiLHoro >mpa, saMeKHHiiero mojkhhhh, ποκρκ-BaeT He^ocTaTOK β nojiHHeHacuiüeHHHX ÄHpHbix KHCJioTax, κο-Topue OTCyTCTBJTK)T β mojiohhom stupe η ηθοοχο,ιιημη άπα noji-otiTHMaJiBHEM, TaK KaK no αθηηημ ne ^ HaTpoB ημθη-HO 25% pacTwreJiLHoro> mpa, saMeKHHiiero mojkhhhh, ποκρκ-Baet He ^ ocTaTOK β nojiHHeHacuiüeHHHX ÄHpHbix KHCJioTax, κο-Topue OTCyTCTBJTK) T β mojiohhom stupe η ηθοοχο, ιιημη άπα noji-

ΗΟΙίβΗΗΟΓΟ pa3BHTHH JteTCKOPO 0ρΓ8ΗΗ3Μβ. ΠρΜΜβρ Ι.ΗΟΙίβΗΗΟΓΟ pa3BHTHH JteTCKOPO 0ρΓ8ΗΗ3Μβ. ΠρΜΜβρ Ι.

K 387 κγ MOJiOKa c MaccpEoft ÄOJieii Knpa 3,655, ÖejiKa 3,2^ κ 40,2 κγ CJDiBOK c MaccoBOü AOJieli Hnpa 30$, öejnca 2% jioöaBJiaioT 9 κγ KyKypy3Horo Macjia, npejtBapHTejiiHO ΒΗΘCH B Hero E 333HCHIZiOCTH OT ΚΟΗΙΙβΗΤΌβΙΙΗΗ B MaCJIHHOM pacTBope xnpopacTBopHMHe BHTaMHHH A1Ji2, Ξ ho: 0,0005, O1OOCOI, 0,0085 κγ.K 387 κγ MOJiOKa c MaccpEoft ÄOJieii Knpa 3,655, ÖejiKa 3.2 ^ 40.2 κ κγ CJDiBOK c MaccoBOü AOJieli hnpa 30 $, öejnca 2% jioöaBJiaioT 9 κγ KyKypy3Horo Macjia, npejtBapHTejiiHO ΒΗΘCH B Hero E 333HCHIZiOCTH OT ΚΟΗΙΙβΗΤΌβΙΙΗΗ B MaCJIHHOM pacTBope xnpopacTBopHMHe BHTaMHHH A 1 Ji 2 , Ξ ho: 0.0005, O 1 OOCOI, 0.0085 κγ.

JI1JiH nojirqeHHfl MejiKO^HcnepcKoit jsicobohJI 1 JiH nojirqeHHfl MejiKO ^ HcnepcKoit jsicoboh

MOJlOiJEXHKHpOByK) OCHOBy ΓΟΜΟΓΘΗΕ3Ηρ7!0Τ ΙΊ CMeiDI'IEaiOT C paCT ΒΟρΟϊί yrjieBOÄHHX ΚΟΜΠΟΗβΗΤΟΕ. ÄJ1H ΟΗΗΗβΗΗΗ opOJ3.HJIi.HHX CBOHCTB JiaKT03H ΚΟρΟΒΒβΓΟ MOJIOKa B CMeCi ÄOOaBJlflKTMOJlOiJEXHKHpOByK) OCHOBy ΓΟΜΟΓΘΗΕ3Ηρ7! 0Τ ΙΊ CMeiDI'IEaiOT C paCT ΒΟρΟϊί yrjieBOÄHHX ΚΟΜΠΟΗβΗΤΟΕ. ÄJ1H ΟΗΗΗβΗΗΗ opOJ3.HJIi.HHX CBOHCTB JiaKT03H ΚΟρΟΒΒβΓΟ MOJIOKa B CMeCi ÄOOaBJlFLKT

34.4 κγ caxapa-necKa (3,44^ onTHMajiBHOe -3Ha^eHHe) H34.4 κγ caxapa-necKa (3.44 ^ onTHMajiBHOe -3Ha ^ eHHe) H

22.5 KT cojiOÄOBoro aKCTpaKTa c MaccoBOß aojiea cyxHx BeuteCTB - 74$, ^ϊτο cooTBeTCTByeT 17 κτ cyxoii MaJILTOSH HJiH 1,7%, Bcero AOOaEJiHeT 7,0^ yrjiesoÄOB.22.5 KT cojiOÄOBoro aKCTpaKTa c MaccoBoss aojiea cyxHx PreyCTB - 74 $, ^ οτο cooTBeTCTByeT 17 κτ cyxoii MaJILTOSH HJiH 1.7%, Bcero AOOaEJiHeT 7,0 ^ yrjiesoÄOB.

BOÄHHM KOMIlOHeHT - ΑβΚΟΤρΗΗ-ΜβΛΐΤΟββ, ΗΜβΗΗΟ 1,7% OÖeC-pOCT όΗφΗΑΟόβΚΤβρΗϋ npH CKBaiHHBaHEH.BOÄHHM KOMIlOHeHT - ΑβΚΟΤρΗΗ-ΜβΛΐΤΟββ, ΗΜβΗΗΟ 1,7% OÖeC-pOCT όΗφΗΑΟόβΚΤβρΗϋ npH CKBaiHHBaHEH.

pacTBopHßT B 406,9 κτ πητβθβοΓι bo^h c τθμ-nepaTypofi 500C, φΐυΐΒτργτοτ. CMeuuiBaiOT c roMoreHHSHpoBaH-höh npH 20 MIIa μολοώιο-χιιροβοη ocHOBoä. IIacTepH3yioT npn TewinepaType 950C (Biwepaaca 30 MHHyr) a- oxnaswaKT άο τβΜ-nepaTypu 400C. Bhocht IO/o 3aKsacKH ^hcthx KyjiBTyp οηφη-ÄOöaKTepzÄ, npenapaT cepHOKHCJioro aejie3a (Π) - 0,033 η BOÄOpaCTEOpHMHe BHTaMHHH B ΚΓ! C - 0,05, FP - 0,004, B6 - 0,0002, B1 - 0,0003, B2 - 0,0001, B3 - 0,0015, B0 - 0,00004. GviecB CKBauiHBaioT πρίί TewnepaType 370CpacTBopHTT B 406.9 κτ πητβθβοΓι bo ^ hc τθμ-nepaTypofi 50 0 C, φΐυΐΒτργτοτ. CMeuuiBaiOT c roMoreHHSHpoBaH-height npH 20 MIIa μολοώιο-χιιροβοη ocHOBoä. IIacTepH3yioT npn TewinepaType 95 0 C (Biwepaaca 30 MHHyr) a- oxnaswaKT άο τβΜ-nepaTypu 40 0 C. Bhocht IO / o 3aKsacKH ^ hcthx KyjiBType οηφη-ÄOöaKTepzÄ, npenapaT cepHOKHCJioro aejie3a (Π) - 0,033 η BOÄOpaCTEOpHMHe BHTaMHHH B ΚΓ! C - 0.05, FP - 0.004, B 6 - 0.0002, B 1 - 0.0003, B 2 - 0.0001, B 3 - 0.0015, B 0 - 0.00004. GviecB CKBauiHBaioT πρίί TewnepaType 37 0 C

U8F7- -57Γ3-ΪU8F7-57Γ3-Ϊ

0,0015, Bc - 0,00004. CMecB cKBaiittiBaioT πρπ TeMnepaType 370C ao khcjiothocth 5O0T, 3aTeM nepeMemnBaioT η HanpaB-JIHiOT na PO3JMB. Pa3JfflBai-0T προΑΥΚτ β rpajiyHpoBaHHHe Oy-THJKHKH BMe CTHMO CTBK) 200 MJI, ΥΚ/ΠΟρίΙΒαΙΟΤ H HanpaBJIHMT Ha oxjiaaweHHe, β xojioAHjiBHyio KaMepy.0.0015, B c - 0.00004. CMecB cKBaiittiBaioT πρπ TeMnepaType 37 0 C ao khcjiothocth 5O 0 T, 3aTeM nepeMemnBaioT η HanpaB-JIHiOT na PO3JMB. Pa3JfflBai-0T προΑΥΚτ β rpajiyHpoBaHHHe Oy-THJKHKH BMe CTHMO CTBK) 200 MJI, ΥΚ / ΠΟρίΙΒαΙΟΤ H HanpaBJIHMT Ha oxjiaaweHHe, β xojioAHjiBHyio KaMepy.

KhCJIOMOJIO^HHH npOffiTKT '1BHCPHJIHH1^nPeACTaBJlHeT CQÖOäKhCJIOMOJIO ^ HHH npOffiTKT ' 1 BHCPHJIHH 1 ^ nPeACTaBJlHeT CQÖOä

ojcHopojmyio Maccy c jierraiM χ^οπβθβηαηημ HapynieHHHM crycT-HMeeT WCTHJi KHCJIOMOJIOtIHHt CJISAKOBaTHZ BKyC, C npHBKycoM cojiOBOBoro 3KCTpaKTa η jieTy^nx khcjiot. npojtyKTa - MOJioHHO-oejiHu hjih κρβΜ0ΒΗίίο Khcjiothoctb β npe^ejiax 50-650T. CocTaB npo,nyKTaojcHopojmyio Maccy c jierraiM χ ^ οπβθβηαηημ HapynieHHHM crycT-HMeeT WCTHJi KHCJIOMOJIOtIHHt CJISAKOBaTHZ BKyC, C npHBKycoM cojiOBOBoro 3KCTpaKTa η jieTy ^ nx khcjiot. npojtyKTa - MOJioHHO-oejiHu hjih κρβΜ0ΒΗίί ο Khcjiothoctb β npe ^ ejiax 50-65 0 T. CocTaB npo, nyKTa

K JKeHCKOMy MOJIOKy, flaeT BO3M0KHOCTB erO B Ka^eCTBe IlHTaHHH npn HCKyCCTSeHHOM ^eTeH co jjhh pojKfleHHH AO 2-x MecHiieB, a HH3KanK JKeHCKOMy MOJIOKY, FLÄDT BO3M0KHOCTB erO B Ka ^ eCTBe IlHTaHHH npn HCKyCCTSeHHOMe ^ eTeH cojjhh pojKfleHHH AO 2-x MecHiieB, a HH3Kan

KHCJIOTHOCTB n03B0JIHeT ΠρΗΜβΗΗΤΒ ΘΓΟ ,HJIfI BCKapMJIHBaHHH HeAOHonieHHBix iteTet. Khcjiomojio^hhm npo^yKT COAepSCaiUHH Β I MJI ^o IO 2CHBHX KJieTOK HBJIHeTCH 3φφβΚΤΗΒΗΒΙΜ Jie^eOHHM Cpe^CTBOM ΠρΗ cMeiiiaHHOM n TpyiiHOM BCKapMJiHBaHHH ^eTeH οτ O I ro,a;a.KHCJIOTHOCTB n03B0JIHeT ΠρΗΜβΗΗΤΒ ΘΓΟ, HJIfI BCKapMJIHBaHHH HeAOHonieHHBix iteTet. Khcjiomojio ^ hhm npo ^ yKT COAepSCaiUHH Β I MJI ^ o IO 2CHBHX KJieTOK HBJIHeTCH 3φφβΚΤΗΒΗΒΙΜ Jie ^ eOHHM Cpe ^ CTBOM ΠρΗ cMeiiiaHHOM n TpyiiHOM BCKapMJiHBaHHH ^ eTeH οτ O I ro, a; a.

CpaBHHTejiBHHe AaHHHe no q?H3HK0-xnMiraecK0My H MHKpOOHOJIOrH^eCKOMy COCTaBy H3BeCTHHX HCpaBHHTejiBHHe AaHHHe no q? H3HK0-xnMiraecK0My H MHKpOOHOJIOrH ^ eCKOMy COCTaBy H3BeCTHHX H

Taojnma ITaojnma I

a SeHCKoe ΑπηαοΦ^β- Khcjiomojio^i- Khcjiomojio^-a SeHCKoe ΑπηαοΦ ^ β- Khcjiomojio ^ i- Khcjiomojio ^ -

noKa3aTejief mojioko nan CMecB hhS ηθπητοκ ηηη ποο,ιπγκτnoKa3aTejief mojioko nan CMecB hhS ηθπητοκ ηηη ποο, ιπγκτ

"MajiiOTKa" "Mapyiympy" "ΒπφΐϋΐΗΗ""MajiiOTKa" "Mapyiympy" "ΒπφΐϋΐΗΗ"

(aHajicr) (προτοτΗπ)(aHajicr) (προτοτΗπ)

HcnojiB3yeMaa HaTypajiB- cyx°e ueJiB- HaTypajiBHoeHcnojiB3yeMaa HaTypajiB- c yx ° e ueJiB- HaTypajiBHoe

MOJIO-^HaH HOe MOJIO- HOe MOJIOKO MOJIOKOMOJIO - ^ HaH Hoe MOJIO- HOe MOJIOKO MOJIOKO

OCHOBa KO, · CJIHBKHOCHOBA KO, · CJIHBKH

CJIHBKHCJIHBKH

3aKBacKa Ha anHSOgmiB- οκφΗΑΟόακ- öHomno-3aKBacKa Ha toHSOgmiB- οκφΗΑΟόακ- öHomno-

^hcthx KyjiB- HHe OaKTe- Te pirn OaicTepnn^ hcthx KyjiB- HHe OaKTe- Te pirn OaicTepnn

Typax punTypax pun

V\V \

ι. Ιι. Ι ο i ^ !ο i ^! •a ! I• a! I 44 •• j 5j 5 KojnreecTBOKojnreecTBO KHBHX KJie-KHBHX KJie- TOK B I MJITOK B I MJI npo,nyKTanpo, nyKTa 10'10 ' IOIO KHCJIOTHOCTB,KHCJIOTHOCTB, OmOm 50-7050-70 50-6550-65 pHpH -- 4,3-4,44.3-4.4 5,3-5,45.3-5.4 4,6-4,74.6-4.7 MaccoBaa AOJIfI, % MaccoBaa AOJIfI, % SUPSUP 3,53.5 3,53.5 3,33.3 3,53.5 Be JiOKBe Jiok 1,V-1,81, V-1.8 1,71.7 3,33.3 1,6-1,71.6-1.7 yrjieBOÄHyrjieBOÄH 7,07.0 7,07.0 11,011.0 7,07.0 B TOMB TOM jiaKTOsajiaKTOsa 7,07.0 2,0-2,22.0-2.2 4,84.8 2,0-2,22.0-2.2 CaxaposaCaxaposa -- 3,43.4 -- 3,43.4 mmhfoSTmmhfoST —- 1,71.7 rjiK)K03arjiK) K03a —- —- 2,92.9 φΡ3ΓΕΓΓΟ3αφΡ3ΓΕΓΓΟ3α -- 2,52.5 -- BHTaMHHHBHTaMHHH A„a2,E,c,A "a 2 , E, c, AA A,Ä2,E,C,A, Ä 2 , E, C, B3»B6'Bc B 3 » B 6 ' B c B3 »Bc »B6 B 3 » B c» B 6 npenapaTnpenapaT —- rjnme ροrjnme ρο CepHOKHC-CepHOKHC- X6JI63a ,X6JI63a, φό cc5aT TSJUiL φό cc5aT TSJUiL JIO w ΛνΘ JXO 3 OJIO w ΛνΘ JXO 3 O -I-I caxapaTcaxapaT \ JJJ BQJISHT" \ YYY BQJISHT " X6JI63aX6JI63a Hoe (33,0)Hoe (33.0) 33,033.0

B Taöjnme 2 npejicTaBJieHa 3aBHCHM0CTi> khcjiothocth η όκφΐηοόακτθρίΐίί β γοτοβομ npo^yKTe οτ προΐίθΗΤ-B Taöjnme 2 npejicTaBJieHa 3aBHCHM0CTi> khcjiothocth η όκφΐηοόακτθρίΐίί β γοτοβομ npo ^ yKTe οτ προΐίθΗΤ-

ΗΟΓΟ, COaepJKaHHfl B ΗβΜΗΟΓΟ, COaepJKaHHfl B ΗβΜ

; ο C 7; ο C 7

ZCiSZIZCiSZI

Taöjnma 2Tao'nma 2

% coßepjKamtö KiicJioTHocTi>, T 3a KojnreecTBO οΉφΗΛοόβκ- % coßepjKamtö KiicJioTHocTi>, T 3a KojnreecTBO οΉφΗΛοόβκ-

ΒΘΚΟΤρΗΗ- 7 ^aC CKBailIHBaHHH TepHH B I MJI fOTOBO-ΒΘΚΟΤρΗΗ- 7 ^ aC CKBailIHBaHHH TepHH B I MJI PHOTOBO

MaJEbTO3H Γ0 npOÄJTKTaMaJEbTO3H Γ0 npOÄJTKTa

. 0,6 ' S ' 8,2-I0ö ", 0,6 'S ' 8,2-I0 ö "

0,8 50 I-IO9 0.8 50 I-IO 9

. 1,2 60 3·Ι09 , 1,2 60 3 · Ι0 9

1,7 65 5-I09 1.7 65 5-I0 9

2 II BHme - TeMHHM IiBeT CMeCH, CIUILHHM npHBKyC COJIOÄOEOrO 3KCTDSKTa2 II BHme - TeMHHM IiBeT CMeCH, CIUILHHM npHBKyC COJIOÄOEOrO 3KCTDSKTa

1 Γ 1 Γ

Claims (4)

ZUTO ο'ϋΑ Ή30ΒΡΞΤΕΗΚΗο'ϋΑ Ή30ΒΡΞΤΕΗΚΗ üiiüi dejiKH, müiiüi dejiKH, m »up, jiaKT037, MHHepajiBHHe Beii;ecT3a, BHTaMHH A, epHH κ souy, oTjnnaiamiäoH τθμ, ψιό, c nejiBio onojionreecKOH iieHHOcTH η jieneoHKX cBOKCTB oh itonojiHHTejiBHO coflepsKHT ^eKcrpKH-MajiBTOsy, caxapo3y, paCTHTeJiBHHiI siip, BHTaMHHH JI2,E1C,Bj· ,Bp,Bg1Bg^B0,PP, a β KaHecT3e MHHepajiBHtix semscTB ncnojiBsyioT npenapa? sejie30 npn cjieayramix οοοτηοιιιθηηηχ iinrpejuieHTOB b Mace.»Up, jiaKT037, MHHepajiBHHe Beii; ecT3a, BHTaMHH A, epHH κ Souy, oTjnnaiamiäoH τθμ, ψιό, c nejiBio onojionreecKOH iieHHOcTH η jieneoHKX cBOKCTB oh itonojiHHTejiBHO coflepsKHT ^ eKcrpKH-MajiBTOsy, caxapo3y, paCTHTeJiBHHiI siip, BHTaMHHH JHA2, E 1 C, Bj ·, Bp, Bg 1 Bg ^ B 0 , PP, a β KaHecT3e MHHepajiBHtix semscTB ncnojiBsyio npenapa? sejie30 npn cjieayramix οοοτηοιιιθηηηχ iinrpejuieHTOB b Mace. MOJIO^iHi! H paCTPtTeJIBHUH AHpH 3,4-3,6MOJIO ^ iHi! H paCTPtTeJIBHUH AHpH 3,4-3,6 jiaKT03a · 2,0-2,2jiaKT03a · 2.0-2.2 .ÄeKCTpHHHwaJii)T03a 1,6-1,8.ÄeKCTpHHHwaJii) T03a 1.6-1.8 caxapo3a 3,3-3,5caxapo3a 3,3-3,5 oejiKH : 1,6-1,8oejiKH : 1.6-1.8 BO.ua · BO.ua · β I mji IO°-IOβ I mji IO ° -IO npenapaT cepHOKHCJioro mejiesa, mjih 32,5-33,5npenapaT cepHOKHCJioro mejiesa, mjih 32,5-33,5 BHTaMHHtI, MJIH-"1 64,0-66 , O.BHTaMHHTI, MJIH - " 1 64,0-66, O. 2. Khcsjioi4Ojio^hh2 προ£7κτ no n.I, β Ka^:ecTBe pacTHTejiBHoro sapa HcnojiB3yicT KyKypy3Hoe2. Khcsjioi4Ojio ^ hh2 προ £ 7κτ no n.I, β Ka ^: ecTBe pacTHTejiBHoro sapa HcnojiB3yicT KyKypy3Hoe HJIH KOKOCOBOe IiJIH 110,1!.COJIHeHHOe HJlH OJOIBKOBOe MaCJIO,HJIH KOKOCOBOe IiJIH 110.1! .COJIHeHHOe HJlH OJOIBKOBOe MaCJIO, cooTHOcieHHe μο.ιοηηογο η pacTHTejiBHoro scnpos y 3:1.cooTHOcIEHHe μο.ιοηηογο η pacTHTejiBHoro scnpos y 3: 1. ÜCTO^HHKH HHQTQpwauHH, ΠρΠΗΏΤΗΘ EO ΒΗΗΜβΗΗβÜCTO ^ HHKH HHQTQpwauHH, ΠρΠΗΏΤΗΘ EO ΒΗΗΜβΗΗβ 1. CMecH aiiHnoÄiuiLHüe; "MajnoTKa" ii ",1. CMecH aiiHomeAiuiLHüe; "MajnoTKa" ii ", TY 49650-80, EEefleHH 01.03·. 80- ' · .TY 49650-80, EefleHH 01.03 ·. 80- '·. 2. SypHaJi New Food Industry 1978, T .20, B 8, c. 17-23, H2. SypHaJi New Food Industry 1978, T .20, B 8, c. 17-23, H 1 ] Q Q 7 . /. ~ "7 C Q .;1] Q Q 7. /. ~ "7 C Q.;
DD85273191A 1984-02-29 1985-02-12 SAUER MILK PRODUCT "BIFILIN" DD266921A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU843706834A SU1351560A1 (en) 1984-02-29 1984-02-29 Sour milk product "bifilin"

Publications (1)

Publication Number Publication Date
DD266921A3 true DD266921A3 (en) 1989-04-19

Family

ID=21105860

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85273191A DD266921A3 (en) 1984-02-29 1985-02-12 SAUER MILK PRODUCT "BIFILIN"

Country Status (14)

Country Link
JP (1) JPS61501247A (en)
AU (1) AU4155485A (en)
BG (1) BG46918A1 (en)
CA (1) CA1227082A (en)
CS (1) CS93585A1 (en)
DD (1) DD266921A3 (en)
DE (2) DE3590083T (en)
FI (1) FI853814L (en)
FR (1) FR2560013B1 (en)
GB (1) GB2171586B (en)
IT (1) IT1189721B (en)
SE (1) SE451938B (en)
SU (1) SU1351560A1 (en)
WO (1) WO1985003848A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673812B1 (en) * 1991-03-13 1994-04-01 Roussel Uclaf NOVEL COMPOSITIONS FOR USE IN DIETETICS AND THERAPEUTICS AND CONTAINING A PARTICULAR COMBINATION OF CARBOHYDRATES AND THEIR APPLICATIONS.
SE9803698L (en) 1998-10-26 2000-04-27 Ericsson Telefon Ab L M Methods and devices in a telecommunication system
US6383534B1 (en) * 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
FI123158B (en) * 2009-05-04 2012-11-30 Valio Oy Milk protein product and process for its production

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1948378A1 (en) * 1969-09-24 1971-04-01 Rolf Dr Schuler Vitamin-enriched soured milk products
SU448852A1 (en) * 1973-06-29 1974-11-05 Институт Питания Академии Медицинских Наук Ссср Method for the production of dry nutritional formula for feeding young children
SU483100A1 (en) * 1973-12-17 1975-09-05 Институт питания АМН СССР Method for the production of fermented milk nutrient mixture for feeding premature and sick young children
JPS5283975A (en) * 1976-01-01 1977-07-13 Yakult Honsha Kk Method of producing fermented milk product containg living cell of bifidus strain
CH621048A5 (en) * 1977-04-27 1981-01-15 Nestle Sa
SU663364A1 (en) * 1977-05-27 1979-05-25 Институт Питания Академии Медицинских Наук Method of producing paste-like cultured milk product for babies
SU863639A1 (en) * 1979-12-25 1981-09-15 Всесоюзный Научно-Исследовательский Институт Молочной Промышленности Bifidobacterium adoescentis ms-42 strain employed for production of sour-milk productts and method of preparing leaven of bifidobacteria for sour-milk products
AR231215A1 (en) * 1982-06-15 1984-10-31 Cpc International Inc PROCEDURE FOR THE PREPARATION OF AN ACIDIFIED DAIRY PRODUCT AND PRODUCT SO OBTAINED

Also Published As

Publication number Publication date
GB8523399D0 (en) 1985-10-23
CS93585A1 (en) 1988-02-15
AU4155485A (en) 1985-09-24
GB2171586A (en) 1986-09-03
SE8504488L (en) 1985-09-27
IT1189721B (en) 1988-02-04
CA1227082A (en) 1987-09-22
FR2560013B1 (en) 1989-12-15
JPS61501247A (en) 1986-06-26
DE3590083C2 (en) 1990-06-21
BG46918A1 (en) 1990-04-16
DE3590083T (en) 1986-03-13
SE451938B (en) 1987-11-09
FR2560013A1 (en) 1985-08-30
WO1985003848A1 (en) 1985-09-12
GB2171586B (en) 1988-06-15
FI853814A0 (en) 1985-10-02
FI853814L (en) 1985-10-02
SE8504488D0 (en) 1985-09-27
IT8541522A0 (en) 1985-02-28
SU1351560A1 (en) 1987-11-15

Similar Documents

Publication Publication Date Title
Von der Weid et al. Antimicrobial activity of Paenibacillus peoriae strain NRRL BD‐62 against a broad spectrum of phytopathogenic bacteria and fungi
Hohnadel et al. Specificity of pyoverdine-mediated iron uptake among fluorescent Pseudomonas strains
EP0835120B2 (en) Use of an essential oil comprising thymol and carvacrol for the manufacture of a pharmaceutical composition for the treatment or prvention of coccidiosis in poultry
US20080102043A1 (en) Antimicrobial flavor and oral care compositon containing the same
DK1010372T3 (en) Bakery products comprising live lyophilized lactic acid bacteria
DD266921A3 (en) SAUER MILK PRODUCT "BIFILIN"
PL262107A1 (en) Novel microorganism,method of obtaining them and pesticide
ATE290391T1 (en) ORAL ADMINISTRATION OF LACTOBACILLUS FOR THE TREATMENT AND PREVENTION OF UROGENITAL INFECTIONS
PL315778A1 (en) Oil-in-water type emulsion
ZA983386B (en) Pourable fat compositions.
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
CY1108646T1 (en) LACTIC ACID BACTERIUM BACTERIA FOR TREATMENT OF BACTERIAL INFECTIONS WITH SIDS
NO20063410L (en) Probiotic tablet formulations
BR9809000A (en) Antimicrobial combinations of sorbate, dialkyl dicarbonate natamycin for use in food products
HRP20110933T1 (en) Long-life probiotic food product
US6599514B1 (en) Antifungal composition
WO2024076586A3 (en) Lipid encapsulated probiotic compositions
EP1854354A1 (en) Agent for enhancing antiseptic power
Bezirtzoglou et al. Effect of the feeding practices on the establishment of bacterial interactions in the intestine of the newborn delivered by cesarian section
de Castro et al. Simultaneous hydrolysis of proteins from different sources to enhance their antibacterial properties through the synergistic action of bioactive peptides
US8673865B2 (en) Agent for enhancing antiseptic power
KR20040083742A (en) Antimicrobial composition comprising grape fruit seed extract and sodium bicarbonate and preparation method thereof
US20100239561A1 (en) SURFACE SANITIZER FOR THE FOOD INDUSTRY BASED ON THREE NEW LACTIC ACID BACTERIA THAT HAVE ANTAGONISTIC ACTION AGAINST Listeria monocytogenes, THE MICROORGANISM THAT CAUSES LISTERIOSIS IN HUMANS
VLAICU et al. Effect of a blend of commercial oils on growth performance and intestinal microflora population in broiler chickens.
MX2022010253A (en) Cocoa composition.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee
ENJ Ceased due to non-payment of renewal fee